Company: PTPI
Filing Date: 2025-11-07
Form Type: 8-K
Source: 0001104659-25-108552
Chunk: 0

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-11-07
Form: 8-K
Item: Item 3.01
Chunk 0
---
Item 3.01. Notice of Delisting
or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On
November 3, 2025, the Nasdaq Stock Market (“ Nasdaq”) notified Petros Pharmaceuticals, Inc. (the “ Company”) that
on November 7, 2025, it intended to announce the delisting of the Company’s common stock, par value $0.0001 (the “ Common Stock”).
The Common Stock was suspended from trading on The Nasdaq Capital Market on May 22, 2025, and has been trading on the OTCID®
Basic Market (the “ OTCID”) under the symbol “ PTPI” since July 1, 2025. Nasdaq will file a Form
25 with the Securities and Exchange Commission to complete the delisting in accordance with Rule 12d2-2 promulgated under
the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), which will deregister the Company’s Common
Stock under Section 12(b) of the Exchange Act. The delisting will become effective ten days after the Form 25 is filed. The Common
Stock will continue trading on the OTCID without disruption and the Company will remain subject to reporting obligations under Sections
13 and 15(d) of the Exchange Act.

SIGNATURES